Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Emergency Optimization of UTI Antibiotic Therapy: "Fluoroquinolones and Third-Generation Cephalosporins Under the Spotlight"

NCT07559318 is registered in ClinicalTrials.gov with Centre Hospitalier Intercommunal Creteil as lead sponsor.

NCT NCT07559318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07559318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Emergency Optimization of UTI Antibiotic Therapy: "Fluoroquinolones and Third-Generation Cephalosporins Under the Spotlight"
Lead sponsor
Centre Hospitalier Intercommunal Creteil
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2026
Completion date
January 1, 2027
Enrollment
330 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

antiobiotic stewardship, emerging infectious disease, urinary tract infections